Nubeqa Tablet 112's (7x16's)

Nubeqa Tablet 112's (7x16's) belongs to a group of medicines known as androgen receptor inhibitors. It is used to treat non-metastatic castration-resistant prostate cancer and metastatic hormone-sensitive prostate cancer (mHSPC) in combination with docetaxel. Non-metastatic castration-resistant prostate cancer (nmCRPC) is prostate cancer that has not spread but continues to grow despite low testosterone levels. Metastatic hormone-sensitive prostate cancer (mHSPC) is a cancer that has spread to other parts of the body but still responds to testosterone-lowering treatments.

Nubeqa Tablet 112's (7x16's) contains Darolutamide, which works by inhibiting the effects of androgens, the hormones that promote prostate cancer growth. By blocking androgen stimulation, Nubeqa Tablet 112's (7x16's) helps slow the progression of cancer and limits its spread.

Take Nubeqa Tablet 112's (7x16's) for the duration prescribed by your doctor based on your medical condition. Some common side effects may include abnormal liver function test, decreased white blood cell count (neutropenia), tiredness, pain in your arms, hands, legs, or feet, and rash. These effects are usually temporary and do not require medical attention. However, if they continue or worsen, see your doctor for advice.

Nubeqa Tablet 112's (7x16's) is for use in men only. Pregnant women should not take this medication as it may harm the fetus. Before taking Nubeqa Tablet 112's (7x16's), inform your healthcare provider about any medical conditions you have, including heart problems, high blood pressure, diabetes, high cholesterol levels, seizures, brain injury, stroke, brain tumors, or any kidney or liver problems. Nubeqa Tablet 112's (7x16's) may reduce male fertility and affect the ability to father children. Talk to your doctor if you have concerns regarding fertility.

Nubeqa Tablet 112's (7x16's) contains darolutamide, an androgen receptor inhibitor. It is used to treat non-metastatic castration-resistant prostate cancer (nmCRPC) and metastatic hormone-sensitive prostate cancer (mHSPC). Most prostate cancers need testosterone to grow, and in men, the testicles are the main source of testosterone production. Nubeqa Tablet 112's (7x16's) works by inhibiting androgen receptors, preventing testosterone from stimulating cancer cell growth and slowing down the spread of prostate cancer.

Do not take Nubeqa Tablet 112's (7x16's) if you are allergic or hypersensitive to any of its components. Before taking Nubeqa Tablet 112's (7x16's), inform your healthcare provider about any medical conditions you have, including heart problems, high blood pressure, diabetes, high cholesterol levels, seizures, brain injury, stroke, brain tumors, or any kidney or liver problems. Pregnant women should not take this medication as it may harm the fetus. If taken during pregnancy, consult a doctor immediately. Nubeqa Tablet 112's (7x16's) is for use in men only; it is not recommended for use in female patients and children.